Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.20% | 7.00% | 34.30% | -0.46% | 316.00% |
| Total Depreciation and Amortization | 273.70% | -156.51% | -2.19% | 1.52% | 244.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.54% | -17.51% | -12.75% | 125.57% | -88.23% |
| Change in Net Operating Assets | 80.94% | 192.55% | -322.40% | 104.32% | -298.65% |
| Cash from Operations | -23.37% | 10.10% | 5.16% | 198.75% | -71.91% |
| Capital Expenditure | 30.22% | 6.67% | -53.45% | -10.40% | -9.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | 601.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.85% | -56.47% | -- | -100.00% | -70.87% |
| Cash from Investing | 44.35% | -21.32% | 1.76% | -1,078.68% | 49.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -50.00% | 13.04% | 8.00% |
| Issuance of Common Stock | 61.34% | -25.15% | 532.18% | -79.83% | 277.37% |
| Repurchase of Common Stock | 83.23% | -27,383.44% | 87.49% | 86.44% | 90.77% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.60% | 0.27% | -0.38% | -0.21% | -0.46% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 149.34% | 22.26% | 12.80% | -10.82% | 51.13% |
| Foreign Exchange rate Adjustments | 4.26% | 78.28% | -387.65% | 134.13% | -109.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.44% | 48.60% | 32.32% | 262.08% | -180.05% |